| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.21 | 8e-06 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.091 | 0.04 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.084 | 0.07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.084 | 0.08 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.094 | 0.08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |